From: A retrospective study of the role of hypercapnia in patients with acromegaly
Variables | Eucapnic acromegaly (n = 69) | Hypercapnic acromegaly (n = 25) | P value |
---|---|---|---|
Age, y | 46.6 ± 11.4 | 45.9 ± 12.9 | 0.836 |
Male, n (%) | 40 (57.8%) | 18 (72.0%) | 0.139 |
BMI, kg/m2 | 26.2 (24.1–29.4) | 27.1 (26.0–29.7) | 0.079 |
BMI > 25, n (%) | 43 (62.3%) | 23 (92.0%) | 0.005 |
disease duration, y | 6.0 (3.0–10.0) | 5.0 (3.0–7.0) | 0.763 |
SSA before surgery | 12 (17.4%) | 5 (20.0%) | 0.768 |
DM, n (%) | 17 (24.6%) | 9 (36.0%) | 0.277 |
Hypertension, n (%) | 26 (37.7%) | 12 (48.0%) | 0.368 |
Current smoking, n (%) | 8 (11.6%) | 4 (16.0%) | 0.572 |
Supine-AHI, /h | 24.7 (11.5–49.5) | 41.6 (16.0–53.9) | 0.409 |
AHI, /h | 14.6 (8.1–31.2) | 37.8 (10.8–57.4) | 0.076 |
AHI > 30, n (%) | 19 (27.5%) | 13 (52.0%) | 0.027 |
ODI, /h | 14.4 (6.1–25.1) | 29.4 (9.9–58.2) | 0.035 |
LSpO2, % | 85.0 (79.5–89.0) | 79.0 (66.0–84.0) | 0.013 |
T90, % | 0.4 (0.0–3.3) | 1.9 (0.3–26.8) | 0.012 |